18 results
PRE 14A
SQZB
SQZ Biotechnologies Co
10 Apr 23
Preliminary proxy
4:31pm
, on a consulting, project and expert witness basis. Before that, from March 2011 to November 2016, Mr. Knopf served as Senior Vice President … . and Patrick V.J.J. Vink, M.D. is an “audit committee financial expert” as defined by applicable SEC rules and has the requisite financial
DEF 14A
SQZB
SQZ Biotechnologies Co
26 Apr 21
Definitive proxy
5:00pm
, on a consulting, project and expert witness basis. Before that, from March 2011 to November 2016, Mr. Knopf served as Senior Vice President and General Counsel … . is an “audit committee financial expert” as defined by applicable SEC rules and has the requisite financial sophistication as defined under the applicable
10-K
vcs9fxdt
18 Mar 21
Annual report
6:31am
424B4
jdn1swr pk7
12 Feb 21
Prospectus supplement with pricing info
5:10pm
DRS
jjajx
1 Feb 21
Draft registration statement
12:00am
424B4
b4v8tcl
30 Oct 20
Prospectus supplement with pricing info
4:54pm
S-1
rzjl4
9 Oct 20
IPO registration
4:59pm
S-1
EX-10.7
65qj28sz
9 Oct 20
IPO registration
4:59pm
DRS/A
kydwmagxvf180yu6
25 Sep 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.7
9zgrxkl2
28 Aug 20
Draft registration statement (amended)
12:00am
DRS/A
v69ii on1
28 Aug 20
Draft registration statement (amended)
12:00am
DRS
i4h4i906ynf9kwse
21 Jul 20
Draft registration statement
12:00am
- Prev
- 1
- Next